CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Press Releases
Original article

FDA Launches Expedited IND Pilot, Begins Accepting Applications

Positive
AI Analysis

Summary

The FDA announced the final design of an Expedited Investigational New Drug (IND) Pilot program and began accepting applications. This is a routine regulatory announcement regarding drug development processes.

Importance:3/10
Sentiment:
0.30
FDAINDRegulatoryExpedited Process

Read the original article

Published by FDA Press Releases on September 15, 2026 1:53 PM

Read Original